Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Ocugen, Inc. is a biotechnology company specializing in gene and cell therapies, biologics, and vaccines for retinal diseases, ocular conditions, and respiratory illnesses. Its core platforms include modifier gene therapy for inherited retinal disorders, regenerative cartilage repair, and inhaled mucosal vaccines. The company develops innovative treatments for blindness, degenerative eye diseases, and respiratory infections, leveraging advanced gene delivery, biologic, and vaccine technologies to address unmet medical needs globally.
This description was generated via AI from an annual report. Updated about 1 year ago.